Healthtech Growth Investors & VC Firms
1270 firms in this list, with a median first check of $1.6M. 311 of them lead rounds. Generated from verified public data and updated continuously.
RBCx
TorontoPre-Seed–Growth
18 people
Remgro / Invenfin ecosystem
StellenboschSeed–Growth
21 people
Windham Capital Partners
New YorkSeries A–Growth$1M – $5M
17 people
Elevar Equity
BengaluruPre-Seed–Growth$1M – $10M
18 people
Mitsui Global Investment
Menlo ParkPre-Seed–Late Stage$500K – $10M
12 people
U.S. International Development Finance Corporation (DFC)
WashingtonGrowth
30 people
Discovery Americas
Mexico CityGrowth
20 people
Beyond Capital Partners
Frankfurt am MainGrowth
25 people
Foresight Group
LondonSeed–Growth$1.3M – $6.3M
18 people
Yunus Social Business Colombia
BerlinSeed–Growth
33 people
PLUS Capital
VeniceSeed–Growth$100K – $1M
14 people
AG Capital Co. Ltd.
TokyoSeed–Growth
1 person
New Capital Partners
BirminghamGrowth$5M – $100M
10 people
Magna Investment
SeoulSeed–Growth
17 people
QVentures
LondonPre-Seed–Growth$127K – $6.3M
5 people
Save the Children Global Ventures
Series A–Growth$150K – $500K
25 people
Xeraya Capital
Kuala LumpurSeed–Growth
22 people
Kennet Partners
LondonSeries B–Growth$8.6M – $32.4M
18 people
Third Point Ventures
Menlo ParkSeed–Late Stage
6 people
Citizen Capital
ParisGrowth$3M – $10.8M
23 people
Builders Fund
San FranciscoGrowth$20M – $200M
22 people
Qatar Investment Authority
DohaGrowth–Late Stage
15 people
TOHOKU University Venture Partners
SendaiPre-Seed–Growth
14 people
Japan Post Capital Co. Ltd.
TokyoSeed–Growth
1 person
Related lists
Growth Investors & VC Firms (4264)Healthtech Investors & VC Firms (4191)Healthtech Seed Investors & VC Firms (3233)Healthtech Investors & VC Firms in North America (2666)Healthtech Investors & VC Firms in United States (2437)Healthtech Series A Investors & VC Firms (2310)Growth Investors & VC Firms in North America (2122)Growth Investors & VC Firms in United States (1838)Growth Investors & VC Firms in Europe (1634)Healthtech Pre-Seed Investors & VC Firms (1468)
Data sourced from public filings and firms' own websites — see our methodology.
























































































